Skip to content
Financing

Issuance of stock under employee stock plans

West Pharmaceutical Services Issuance of stock under employee stock plans increased by 33.3% to $2M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.3%, from $1.9M to $2M. Over 3 years (FY 2021 to FY 2025), Issuance of stock under employee stock plans shows a downward trend with a -3.6% CAGR.

Analysis

StatementCash Flow Statement
SectionFinancing
First reportedQ1 2015
Last reportedQ1 2026Apr 23, 2026
Metric ID: financing_proceeds_from_issuance_of_shares_under_incenti_2a195c

Historical Data

18 periods
 Q2 '21Q3 '21Q4 '21Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$2.1M$1.8M$2M$2M$1.2M$1.8M$1.7M$1.8M$1.8M$2M$1.7M$1.9M$1.6M$1.9M$1.7M$1.8M$1.5M$2M
QoQ Change-14.3%+11.1%+0.0%-40.0%+50.0%-5.6%+5.9%+0.0%+11.1%-15.0%+11.8%-15.8%+18.8%-10.5%+5.9%-16.7%+33.3%
YoY Change+11.1%-40.0%-10.0%+50.0%+11.1%+0.0%+5.6%-11.1%-5.0%+0.0%-5.3%-6.3%+5.3%
Range$1.2M$2.1M
CAGR-1.1%
Avg YoY Growth+0.4%
Median YoY Growth+0.0%

Frequently Asked Questions

What is West Pharmaceutical Services's issuance of stock under employee stock plans?
West Pharmaceutical Services (WST) reported issuance of stock under employee stock plans of $2M in Q1 2026.
How has West Pharmaceutical Services's issuance of stock under employee stock plans changed year-over-year?
West Pharmaceutical Services's issuance of stock under employee stock plans increased by 5.3% year-over-year, from $1.9M to $2M.
What is the long-term trend for West Pharmaceutical Services's issuance of stock under employee stock plans?
Over 3 years (2021 to 2025), West Pharmaceutical Services's issuance of stock under employee stock plans has grown at a -3.6% compound annual growth rate (CAGR), from $7.7M to $6.9M.